Kaleido to fully launch for adults in the Netherlands

Kaleido to fully launch for adults in the Netherlands

Following a successful pilot scheme at a small selection Dutch hospitals, Kaleido has now fully launched in the Netherlands. As the company behind the smallest and lightest insulin pump in the world, at ViCentra we’re proud to announce that our first Kaleidoers...
Kaleido to fully launch for adults in the Netherlands

Kaleido wins at the Transform Awards Europe 2017!

ViCentra is delighted to announce that Kaleido – our hotly-anticipated new insulin delivery system – was awarded Bronze in the category ‘Best visual identity from the healthcare and pharmaceutical sector’ at last week’s eighth annual Transform Awards Europe....
Kaleido to fully launch for adults in the Netherlands

ViCentra announces new Chairman of the Board

Leading late-stage startup ViCentra, a company focused on the development, manufacture and commercialisation of Kaleido, the insulin pump designed to help people with diabetes live life on their own terms, has today announced the appointment of Jan Keltjens to the...
ViCentra’s insulin pump Kaleido fully reimbursed in the Netherlands

ViCentra appoints two new medical and scientific advisors

ViCentra, manufacturer of the Kaleido insulin delivery system, today announced the appointment of Dr. David Kerr and Dr. Fred Storms as medical and scientific advisors to its team. Drs. Kerr and Storms are both internationally recognised experts in the treatment of...